|
G |
NR1I2 |
nuclear receptor subfamily 1 group I member 2 |
increases activity |
EXP |
Clotrimazole results in increased activity of NR1I2 protein |
CTD |
PMID:27732639 |
|
NCBI chr33:23,444,367...23,456,405
Ensembl chr33:23,432,690...23,455,347
|
|
G |
NR1I3 |
nuclear receptor subfamily 1 group I member 3 |
affects binding increases activity |
EXP |
Clotrimazole binds to NR1I3 protein Clotrimazole results in increased activity of NR1I3 protein; Clotrimazole results in increased activity of NR1I3 protein mutant form |
CTD |
PMID:21778469 PMID:27732639 |
|
NCBI chr38:21,252,874...21,257,951
Ensembl chr38:21,253,089...21,258,827
|
|
|
G |
SLC47A1 |
solute carrier family 47 member 1 |
decreases activity |
EXP |
hexaconazole results in decreased activity of SLC47A1 protein |
CTD |
PMID:36669674 |
|
NCBI chr 5:40,643,420...40,679,130
Ensembl chr 5:40,642,784...40,679,946
|
|
G |
SLC47A2 |
solute carrier family 47 member 2 |
decreases activity |
EXP |
hexaconazole results in decreased activity of SLC47A2 protein |
CTD |
PMID:36669674 |
|
NCBI chr 5:40,491,306...40,515,430
Ensembl chr 5:40,491,933...40,540,136
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
decreases expression decreases activity multiple interactions |
EXP |
Ketoconazole results in decreased expression of ABCB1 mRNA Ketoconazole results in decreased activity of ABCB1 protein [Ketoconazole results in decreased activity of ABCB1 protein] which results in decreased transport of Technetium Tc 99m Sestamibi |
CTD |
PMID:19754906 PMID:22620706 |
|
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
|
|
G |
CYP3A12 |
cytochrome P-450 3A12 |
multiple interactions decreases activity |
EXP |
Ketoconazole inhibits the reaction [CYP3A12 protein results in increased hydroxylation of Diazepam] Ketoconazole results in decreased activity of CYP3A12 protein |
CTD |
PMID:15677349 |
|
|
|
|
G |
SLC22A2 |
solute carrier family 22 member 2 |
decreases activity |
EXP |
penconazole results in decreased activity of SLC22A2 protein |
CTD |
PMID:36669674 |
|
NCBI chr 1:49,327,621...49,348,435
Ensembl chr 1:49,327,296...49,348,435
|
|
G |
SLC22A5 |
solute carrier family 22 member 5 |
decreases activity |
EXP |
penconazole results in decreased activity of SLC22A5 protein |
CTD |
PMID:36669674 |
|
NCBI chr11:20,659,023...20,686,359
Ensembl chr11:20,598,888...20,683,087
|
|
G |
SLC47A1 |
solute carrier family 47 member 1 |
decreases activity |
EXP |
penconazole results in decreased activity of SLC47A1 protein |
CTD |
PMID:36669674 |
|
NCBI chr 5:40,643,420...40,679,130
Ensembl chr 5:40,642,784...40,679,946
|
|
G |
SLC47A2 |
solute carrier family 47 member 2 |
decreases activity |
EXP |
penconazole results in decreased activity of SLC47A2 protein |
CTD |
PMID:36669674 |
|
NCBI chr 5:40,491,306...40,515,430
Ensembl chr 5:40,491,933...40,540,136
|
|
|
G |
AHR |
aryl hydrocarbon receptor |
multiple interactions |
EXP |
[2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to prochloraz; [prochloraz binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein; [salicylamide binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to prochloraz |
CTD |
PMID:24389113 |
|
NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions |
EXP |
[prochloraz binds to and results in increased activity of AHR protein] which results in increased activity of CYP1A1 protein |
CTD |
PMID:24389113 |
|
NCBI chr30:37,793,277...37,799,535
Ensembl chr30:37,793,508...37,796,866
|
|
|
G |
SLC22A2 |
solute carrier family 22 member 2 |
decreases activity |
EXP |
tebuconazole results in decreased activity of SLC22A2 protein |
CTD |
PMID:36669674 |
|
NCBI chr 1:49,327,621...49,348,435
Ensembl chr 1:49,327,296...49,348,435
|
|
G |
SLC22A5 |
solute carrier family 22 member 5 |
decreases activity |
EXP |
tebuconazole results in decreased activity of SLC22A5 protein |
CTD |
PMID:36669674 |
|
NCBI chr11:20,659,023...20,686,359
Ensembl chr11:20,598,888...20,683,087
|
|
G |
SLC47A1 |
solute carrier family 47 member 1 |
decreases activity |
EXP |
tebuconazole results in decreased activity of SLC47A1 protein |
CTD |
PMID:36669674 |
|
NCBI chr 5:40,643,420...40,679,130
Ensembl chr 5:40,642,784...40,679,946
|
|
G |
SLC47A2 |
solute carrier family 47 member 2 |
decreases activity |
EXP |
tebuconazole results in decreased activity of SLC47A2 protein |
CTD |
PMID:36669674 |
|
NCBI chr 5:40,491,306...40,515,430
Ensembl chr 5:40,491,933...40,540,136
|
|
|
G |
SLC22A5 |
solute carrier family 22 member 5 |
decreases activity |
EXP |
triticonazole results in decreased activity of SLC22A5 protein |
CTD |
PMID:36669674 |
|
NCBI chr11:20,659,023...20,686,359
Ensembl chr11:20,598,888...20,683,087
|
|
G |
SLC47A1 |
solute carrier family 47 member 1 |
decreases activity |
EXP |
triticonazole results in decreased activity of SLC47A1 protein |
CTD |
PMID:36669674 |
|
NCBI chr 5:40,643,420...40,679,130
Ensembl chr 5:40,642,784...40,679,946
|
|
|
G |
SLC22A5 |
solute carrier family 22 member 5 |
decreases activity |
EXP |
uniconazole results in decreased activity of SLC22A5 protein |
CTD |
PMID:36669674 |
|
NCBI chr11:20,659,023...20,686,359
Ensembl chr11:20,598,888...20,683,087
|
|
G |
SLC47A1 |
solute carrier family 47 member 1 |
decreases activity |
EXP |
uniconazole results in decreased activity of SLC47A1 protein |
CTD |
PMID:36669674 |
|
NCBI chr 5:40,643,420...40,679,130
Ensembl chr 5:40,642,784...40,679,946
|
|